Market Cap 4.55B
Revenue (ttm) 1.10B
Net Income (ttm) 44.34M
EPS (ttm) N/A
PE Ratio 22.26
Forward PE 22.26
Profit Margin 4.03%
Debt to Equity Ratio 3.89
Volume 2,915,000
Avg Vol 2,211,168
Day's Range N/A - N/A
Shares Out 284.09M
Stochastic %K 13%
Beta 1.82
Analysts Sell
Price Target $18.92

Company Profile

Sotera Health Company provides sterilization, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment offers outsourced terminal sterilization and irradiation services using gamma irradiation, ethylene oxide processing, and electron beam irradiation technologies for the medical device, pharmaceutical, and food safety and adv...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 440 262 1410
Address:
9100 South Hills Blvd, Suite 300, Broadview Heights, United States
PrivateProfiteer
PrivateProfiteer Nov. 15 at 9:47 AM
$SHC is currently trading at $15.64, with an RSI of 33.23, indicating it is in oversold territory and may be due for a rebound. The 30-day moving average (MA30) is at $16.23, while the 50-day moving average (MA50) is at $16.11, suggesting a bearish trend as the price is below both MAs. The recent high of $17.78 and low of $15.19 over the past 60 days further illustrate the current price's proximity to the lower end of this range. Directional bias leans towards a potential short-term reversal given the oversold RSI. Suggested entry is at $15.70, with a stop loss at $15.40 to manage risk. Target 1 is set at $16.00, aligning with the MA50, and Target 2 at $16.25, near the MA30. This plan allows for a cautious approach while capitalizing on a possible bounce back. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 15 at 1:09 AM
$SHC: The last close at $16.01 indicates a position near the 60D low of $15.19, suggesting potential for a reversal. The RSI at 35.69 signals that the stock is approaching oversold territory, which may indicate a bullish reversal opportunity. The MA30 at $16.24 is above the current price, indicating short-term resistance, while the MA50 at $16.11 provides support just below the current level. Directional bias leans bullish due to the proximity to the 60D low and the oversold RSI. Suggested entry is at $16.05, slightly above the last close to confirm upward momentum. Set a stop loss at $15.80 to limit risk. Target 1 is at $16.50, aligning with a minor resistance level, and Target 2 is at $16.75, near the 60D high of $17.78. Monitor price action closely, as a break above the MA30 could confirm the bullish bias. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 14 at 4:43 AM
$SHC: The last close at $16.01 indicates a position near the 60D low of $15.19, suggesting potential for a reversal. The RSI at 35.69 signals that the stock is approaching oversold territory, which may indicate a bullish reversal opportunity. The MA30 at $16.24 is above the current price, indicating short-term resistance, while the MA50 at $16.11 provides support just below the current level. Directional bias leans bullish due to the proximity to the 60D low and the oversold RSI. Suggested entry is at $16.05, slightly above the last close to confirm upward momentum. Set a stop loss at $15.80 to limit risk. Target 1 is at $16.50, aligning with a minor resistance level, and Target 2 is at $16.75, near the 60D high of $17.78. Monitor price action closely, as a break above the MA30 could confirm the bullish bias. https://privateprofiteers.com
0 · Reply
JarvisFlow
JarvisFlow Nov. 13 at 10:21 AM
BMO Capital updates rating for Sotera Health ( $SHC ) to Outperform, target set at 19.
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 13 at 2:49 AM
$SHC: The last close is $16.13, with an RSI of 38.93 indicating potential oversold conditions. The stock is trading below its 30-day moving average (MA30) of $16.23 and slightly above its 50-day moving average (MA50) of $16.09, suggesting a neutral to bearish short-term trend. The 60-day high of $17.78 and low of $15.19 create a range that indicates possible volatility. Directional bias is slightly bearish due to the RSI being below 40 and the price under the MA30. However, the proximity to the 60D low could present a buying opportunity if the price stabilizes. Suggested entry: $16.05 (below current close to confirm support). Stop loss: $15.85 (to limit risk below the 60D low). Targets: $16.50 (first resistance level) and $17.00 (near the 60D high). Monitor for any changes in momentum or volume that could impact this plan. https://privateprofiteers.com
0 · Reply
thebadfish843
thebadfish843 Nov. 12 at 8:27 PM
$SHC 👀
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 12 at 2:25 AM
$SHC: The last close is $16.13, with an RSI of 38.93 indicating potential oversold conditions. The stock is trading below its 30-day moving average (MA30) of $16.23 and slightly above its 50-day moving average (MA50) of $16.09, suggesting a neutral to bearish short-term trend. The 60-day high of $17.78 and low of $15.19 create a range that indicates possible volatility. Directional bias is slightly bearish due to the RSI being below 40 and the price under the MA30. However, the proximity to the 60D low could present a buying opportunity if the price stabilizes. Suggested entry: $16.05 (below current close to confirm support). Stop loss: $15.85 (to limit risk below the 60D low). Targets: $16.50 (first resistance level) and $17.00 (near the 60D high). Monitor for any changes in momentum or volume that could impact this plan. https://privateprofiteers.com
0 · Reply
AStrokeOfLuck
AStrokeOfLuck Nov. 6 at 10:42 PM
0 · Reply
JarvisFlow
JarvisFlow Nov. 5 at 7:45 PM
JP Morgan has adjusted their stance on Sotera Health ( $SHC ), setting the rating to Neutral with a target price of 14 → 16.
0 · Reply
JarvisFlow
JarvisFlow Nov. 5 at 6:00 PM
Barclays has adjusted their stance on Sotera Health ( $SHC ), setting the rating to Overweight with a target price of 19 → 20.
0 · Reply
Latest News on SHC
Sotera Health Announces Secondary Offering of Common Stock

Nov 6, 2025, 4:37 PM EST - 8 days ago

Sotera Health Announces Secondary Offering of Common Stock


Sotera Health Company (SHC) Q3 2025 Earnings Call Transcript

Nov 4, 2025, 2:26 PM EST - 10 days ago

Sotera Health Company (SHC) Q3 2025 Earnings Call Transcript


Sotera Health Company (SHC) Q2 2025 Earnings Call Transcript

Aug 8, 2025, 12:51 PM EDT - 3 months ago

Sotera Health Company (SHC) Q2 2025 Earnings Call Transcript


Sotera Health Company (SHC) Q1 2025 Earnings Call Transcript

May 2, 2025, 2:37 PM EDT - 7 months ago

Sotera Health Company (SHC) Q1 2025 Earnings Call Transcript


Sotera Health Reports First-Quarter 2025 Results

May 1, 2025, 7:38 AM EDT - 7 months ago

Sotera Health Reports First-Quarter 2025 Results


Sotera Health Announces First-Quarter 2025 Earnings Release Date

Apr 17, 2025, 5:16 PM EDT - 7 months ago

Sotera Health Announces First-Quarter 2025 Earnings Release Date


Sotera Health Has A Great Deleveraging Path Ahead

Apr 8, 2025, 12:34 PM EDT - 7 months ago

Sotera Health Has A Great Deleveraging Path Ahead


Sotera Health Company (SHC) Q4 2024 Earnings Call Transcript

Feb 27, 2025, 2:15 PM EST - 9 months ago

Sotera Health Company (SHC) Q4 2024 Earnings Call Transcript


Sotera Health Company (SHC) Q3 2024 Earnings Call Transcript

Nov 5, 2024, 5:04 PM EST - 1 year ago

Sotera Health Company (SHC) Q3 2024 Earnings Call Transcript


Sotera Health Company (SHC) Q2 2024 Earnings Call Transcript

Aug 5, 2024, 2:44 PM EDT - 1 year ago

Sotera Health Company (SHC) Q2 2024 Earnings Call Transcript


PrivateProfiteer
PrivateProfiteer Nov. 15 at 9:47 AM
$SHC is currently trading at $15.64, with an RSI of 33.23, indicating it is in oversold territory and may be due for a rebound. The 30-day moving average (MA30) is at $16.23, while the 50-day moving average (MA50) is at $16.11, suggesting a bearish trend as the price is below both MAs. The recent high of $17.78 and low of $15.19 over the past 60 days further illustrate the current price's proximity to the lower end of this range. Directional bias leans towards a potential short-term reversal given the oversold RSI. Suggested entry is at $15.70, with a stop loss at $15.40 to manage risk. Target 1 is set at $16.00, aligning with the MA50, and Target 2 at $16.25, near the MA30. This plan allows for a cautious approach while capitalizing on a possible bounce back. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 15 at 1:09 AM
$SHC: The last close at $16.01 indicates a position near the 60D low of $15.19, suggesting potential for a reversal. The RSI at 35.69 signals that the stock is approaching oversold territory, which may indicate a bullish reversal opportunity. The MA30 at $16.24 is above the current price, indicating short-term resistance, while the MA50 at $16.11 provides support just below the current level. Directional bias leans bullish due to the proximity to the 60D low and the oversold RSI. Suggested entry is at $16.05, slightly above the last close to confirm upward momentum. Set a stop loss at $15.80 to limit risk. Target 1 is at $16.50, aligning with a minor resistance level, and Target 2 is at $16.75, near the 60D high of $17.78. Monitor price action closely, as a break above the MA30 could confirm the bullish bias. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 14 at 4:43 AM
$SHC: The last close at $16.01 indicates a position near the 60D low of $15.19, suggesting potential for a reversal. The RSI at 35.69 signals that the stock is approaching oversold territory, which may indicate a bullish reversal opportunity. The MA30 at $16.24 is above the current price, indicating short-term resistance, while the MA50 at $16.11 provides support just below the current level. Directional bias leans bullish due to the proximity to the 60D low and the oversold RSI. Suggested entry is at $16.05, slightly above the last close to confirm upward momentum. Set a stop loss at $15.80 to limit risk. Target 1 is at $16.50, aligning with a minor resistance level, and Target 2 is at $16.75, near the 60D high of $17.78. Monitor price action closely, as a break above the MA30 could confirm the bullish bias. https://privateprofiteers.com
0 · Reply
JarvisFlow
JarvisFlow Nov. 13 at 10:21 AM
BMO Capital updates rating for Sotera Health ( $SHC ) to Outperform, target set at 19.
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 13 at 2:49 AM
$SHC: The last close is $16.13, with an RSI of 38.93 indicating potential oversold conditions. The stock is trading below its 30-day moving average (MA30) of $16.23 and slightly above its 50-day moving average (MA50) of $16.09, suggesting a neutral to bearish short-term trend. The 60-day high of $17.78 and low of $15.19 create a range that indicates possible volatility. Directional bias is slightly bearish due to the RSI being below 40 and the price under the MA30. However, the proximity to the 60D low could present a buying opportunity if the price stabilizes. Suggested entry: $16.05 (below current close to confirm support). Stop loss: $15.85 (to limit risk below the 60D low). Targets: $16.50 (first resistance level) and $17.00 (near the 60D high). Monitor for any changes in momentum or volume that could impact this plan. https://privateprofiteers.com
0 · Reply
thebadfish843
thebadfish843 Nov. 12 at 8:27 PM
$SHC 👀
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 12 at 2:25 AM
$SHC: The last close is $16.13, with an RSI of 38.93 indicating potential oversold conditions. The stock is trading below its 30-day moving average (MA30) of $16.23 and slightly above its 50-day moving average (MA50) of $16.09, suggesting a neutral to bearish short-term trend. The 60-day high of $17.78 and low of $15.19 create a range that indicates possible volatility. Directional bias is slightly bearish due to the RSI being below 40 and the price under the MA30. However, the proximity to the 60D low could present a buying opportunity if the price stabilizes. Suggested entry: $16.05 (below current close to confirm support). Stop loss: $15.85 (to limit risk below the 60D low). Targets: $16.50 (first resistance level) and $17.00 (near the 60D high). Monitor for any changes in momentum or volume that could impact this plan. https://privateprofiteers.com
0 · Reply
AStrokeOfLuck
AStrokeOfLuck Nov. 6 at 10:42 PM
0 · Reply
JarvisFlow
JarvisFlow Nov. 5 at 7:45 PM
JP Morgan has adjusted their stance on Sotera Health ( $SHC ), setting the rating to Neutral with a target price of 14 → 16.
0 · Reply
JarvisFlow
JarvisFlow Nov. 5 at 6:00 PM
Barclays has adjusted their stance on Sotera Health ( $SHC ), setting the rating to Overweight with a target price of 19 → 20.
0 · Reply
JarvisFlow
JarvisFlow Nov. 5 at 3:59 PM
Piper Sandler has adjusted their stance on Sotera Health ( $SHC ), setting the rating to Neutral with a target price of 15 → 17.
0 · Reply
AStrokeOfLuck
AStrokeOfLuck Nov. 4 at 8:32 PM
0 · Reply
Arcides
Arcides Oct. 2 at 1:28 AM
$SHC Wants to go up
0 · Reply
Doozio
Doozio Sep. 29 at 1:24 AM
$SHC MAMA said 🐒🍌🧠⏰♾️
0 · Reply
NVDAMillionaire
NVDAMillionaire Sep. 4 at 10:38 PM
$SHC Great piece that accurately captures SHC's current position. So if you want to refresh your understanding of SHC or learn about SHC for the first time, this is essential reading. https://beyondspx.com/quote/SHC/sotera-health-sterilization-s-enduring-moat-and-accelerated-growth-nasdaq-shc#analysis
0 · Reply
MillionaireTrader555
MillionaireTrader555 Sep. 4 at 3:06 PM
$SHC huge gap to fill down at $12. And now with a massive stock offering, they will dilute it down there. Great short opportunity.
0 · Reply
MillionaireTrader555
MillionaireTrader555 Sep. 4 at 1:35 PM
$SHC yep, first stop will be down to $12 with two offerings now out there diluting on shareholders!
0 · Reply
MillionaireTrader555
MillionaireTrader555 Sep. 4 at 4:46 AM
$SHC 2 offerings now??? 🤦‍♂️ company is going to drive this right back down to $11!
0 · Reply
DonCorleone77
DonCorleone77 Sep. 4 at 12:58 AM
$SHC Sotera Health 20M share spot secondary; price range $15.20-$15.98
0 · Reply
MillionaireTrader555
MillionaireTrader555 Sep. 4 at 12:30 AM
$SHC I guess many didn’t see another offering has been put out 😬 this is going to tank now and shorts will jump all over it 🤦‍♂️
0 · Reply
OpenOutcrier
OpenOutcrier Aug. 8 at 12:12 PM
$SHC (+7.9% pre) Sotera Health Beats Q2 Estimates, Boosts 2025 Outlook as EBITDA Surges 9.8% https://ooc.bz/l/73228
0 · Reply
Estimize
Estimize Aug. 6 at 12:00 AM
Wall St is expecting 0.17 EPS for $SHC Q2 [Reporting 08/08 BMO] http://www.estimize.com/intro/shc?chart=historical&metric_name=eps&utm_cont
0 · Reply